Greece
· Delayed Price · Currency is EUR Bioter Statistics
Total Valuation
Bioter has a market cap or net worth of EUR 4.92 million. The enterprise value is 188.78 million.
| Market Cap | 4.92M |
| Enterprise Value | 188.78M |
Important Dates
The next estimated earnings date is Friday, December 27, 2024.
| Earnings Date | Dec 27, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Bioter has 16.73 million shares outstanding.
| Current Share Class | n/a |
| Shares Outstanding | 16.73M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | -0.08% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 17.57 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -15.54 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -17.88 |
Financial Position
The company has a current ratio of 0.12
| Current Ratio | 0.12 |
| Quick Ratio | 0.12 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -17.61 |
| Interest Coverage | -0.13 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -1.05% |
| Return on Capital (ROIC) | -1.35% |
| Revenue Per Employee | 56,000 |
| Profits Per Employee | -2.43M |
| Employee Count | 4 |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +8.89% in the last 52 weeks. The beta is 0.56, so Bioter's price volatility has been lower than the market average.
| Beta (5Y) | 0.56 |
| 52-Week Price Change | +8.89% |
| 50-Day Moving Average | 0.28 |
| 200-Day Moving Average | 0.28 |
| Relative Strength Index (RSI) | 49.19 |
| Average Volume (20 Days) | 6,778 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Bioter had revenue of EUR 280,000 and -12.15 million in losses. Loss per share was -0.73.
| Revenue | 280,000 |
| Gross Profit | -54,000 |
| Operating Income | -1.37M |
| Pretax Income | -11.32M |
| Net Income | -12.15M |
| EBITDA | -1.26M |
| EBIT | -1.37M |
| Loss Per Share | -0.73 |
Balance Sheet
The company has 1.66 million in cash and 185.96 million in debt, giving a net cash position of -184.30 million or -11.01 per share.
| Cash & Cash Equivalents | 1.66M |
| Total Debt | 185.96M |
| Net Cash | -184.30M |
| Net Cash Per Share | -11.01 |
| Equity (Book Value) | -123.67M |
| Book Value Per Share | -7.36 |
| Working Capital | -175.30M |
Cash Flow
In the last 12 months, operating cash flow was -10.40 million and capital expenditures -156,000, giving a free cash flow of -10.56 million.
| Operating Cash Flow | -10.40M |
| Capital Expenditures | -156,000 |
| Free Cash Flow | -10.56M |
| FCF Per Share | -0.63 |
Margins
| Gross Margin | -19.29% |
| Operating Margin | -488.93% |
| Pretax Margin | -4,043.21% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | -3,771.43% |
Dividends & Yields
Bioter does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -246.95% |
| FCF Yield | -214.63% |
Stock Splits
The last stock split was on August 9, 2010. It was a reverse split with a ratio of 0.25.
| Last Split Date | Aug 9, 2010 |
| Split Type | Reverse |
| Split Ratio | 0.25 |
Scores
Bioter has an Altman Z-Score of -6.48. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -6.48 |
| Piotroski F-Score | n/a |